Vertex Pharmaceuticals Incorporated (VRTX)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 2,770,200,000 2,912,000,000 2,771,900,000 2,645,600,000
Cost of Revenue 363,000,000 423,400,000 392,600,000 371,900,000
Gross Profit 2,407,200,000 2,488,600,000 2,379,300,000 2,273,700,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 396,400,000 377,600,000 371,800,000 372,200,000
Operating Expenses 1,777,100,000 1,376,300,000 1,263,000,000 5,788,400,000
Operating Income 630,100,000 1,026,000,000 1,116,300,000 -3,514,700,000
Interest Expense 3,000,000 2,800,000 7,500,000 9,900,000
Income Before Tax 730,400,000 1,136,500,000 1,224,100,000 -3,391,200,000
Income Tax Expense 84,100,000 223,500,000 178,700,000 202,400,000
Net Income 646,300,000 913,000,000 1,045,400,000 -3,593,600,000
Per Share
EPS 2.52 3.55 4.05 -13.92
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 11,020,100,000 9,869,200,000 8,930,700,000 7,574,400,000 6,205,683,000
Cost of Revenue 1,530,500,000 1,262,200,000 1,080,300,000 904,200,000 736,300,000
Gross Profit 9,489,600,000 8,607,000,000 7,850,400,000 6,670,200,000 5,469,383,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 1,464,300,000 1,136,600,000 944,700,000 840,100,000 770,456,000
Operating Expenses 9,722,500,000 4,775,000,000 3,485,000,000 3,891,200,000 2,599,993,000
Operating Income -232,900,000 3,832,000,000 4,307,400,000 2,782,100,000 2,856,290,000
Interest Expense 30,600,000 44,100,000 54,800,000 61,500,000 58,151,000
Income Before Tax 248,500,000 4,379,800,000 4,232,400,000 2,730,400,000 3,116,798,000
Income Tax Expense 784,100,000 760,200,000 910,400,000 388,300,000 405,151,000
Net Income -535,600,000 3,619,600,000 3,322,000,000 2,342,100,000 2,711,647,000
Per Share
EPS -2.08 14.05 12.97 9.09 10.44
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 4,569,600,000 10,369,100,000 10,504,000,000 6,795,000,000
Short Term Investments 1,546,300,000 849,200,000 274,500,000 729,900,000
Net Receivables 1,609,400,000 1,563,400,000 1,442,200,000 1,136,800,000
Inventory 1,205,400,000 738,800,000 460,600,000 353,100,000
Total Current Assets 9,596,400,000 14,144,200,000 12,681,300,000 9,560,600,000
Property Plant Equipment 2,584,600,000 1,452,900,000 1,108,400,000 1,424,400,000
Goodwill and Intangibles 1,913,900,000 1,927,900,000 1,691,600,000 1,402,200,000
Total Assets 22,533,200,000 22,730,200,000 18,150,900,000 13,432,500,000
Liabilities
Account Payables 413,000,000 364,900,000 303,900,000 195,000,000
Short Term Debt 92,300,000 83,700,000 89,400,000 46,900,000
Total Current Liabilities 3,564,600,000 3,547,400,000 2,430,600,000 2,142,000,000
Long Term Debt 1,657,200,000 1,449,400,000 471,600,000 887,200,000
Total Liabilities 6,123,600,000 5,149,800,000 4,238,200,000 3,332,500,000
Shareholders Equity
Retained Earnings 9,606,800,000 10,142,400,000 6,522,800,000 3,200,800,000
Total Shareholders Equity 16,409,600,000 17,580,400,000 13,912,700,000 10,100,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 4,569,600,000 10,369,100,000 10,504,000,000 6,795,000,000 5,988,187,000
Short Term Investments 1,546,300,000 849,200,000 274,500,000 729,900,000 670,710,000
Net Receivables 1,609,400,000 1,563,400,000 1,442,200,000 1,136,800,000 885,352,000
Inventory 1,205,400,000 738,800,000 460,600,000 353,100,000 280,777,000
Total Current Assets 9,596,400,000 14,144,200,000 12,681,300,000 9,560,600,000 8,133,379,000
Property Plant Equipment 2,584,600,000 1,452,900,000 1,108,400,000 1,424,400,000 1,284,098,000
Goodwill and Intangibles 1,913,900,000 1,927,900,000 1,691,600,000 1,402,200,000 1,402,158,000
Total Assets 22,533,200,000 22,730,200,000 18,150,900,000 13,432,500,000 11,751,808,000
Liabilities
Account Payables 413,000,000 364,900,000 303,900,000 195,000,000 155,139,000
Short Term Debt 92,300,000 83,700,000 89,400,000 46,900,000 42,434,000
Total Current Liabilities 3,564,600,000 3,547,400,000 2,430,600,000 2,142,000,000 1,877,533,000
Long Term Debt 1,657,200,000 1,449,400,000 471,600,000 887,200,000 889,505,000
Total Liabilities 6,123,600,000 5,149,800,000 4,238,200,000 3,332,500,000 3,064,993,000
Shareholders Equity
Retained Earnings 9,606,800,000 10,142,400,000 6,522,800,000 3,200,800,000 858,669,000
Total Shareholders Equity 16,409,600,000 17,580,400,000 13,912,700,000 10,100,000,000 8,686,815,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -535,600,000 3,619,600,000 3,322,000,000 2,342,100,000
Depreciation & Amortization 207,200,000 181,300,000 148,300,000 125,600,000
Stock Based Compensation 698,500,000 581,200,000 491,300,000 441,400,000
Change in Working Capital -514,800,000 -265,700,000 340,800,000 -105,200,000
Operating Cash Flow -492,600,000 3,537,300,000 4,129,900,000 2,643,500,000
Investing Activities
Capital Expenditure -297,700,000 -258,399,999 -204,700,000 -235,000,000
Investments -297,700,000 -258,399,999 -204,700,000 -235,000,000
Investing Cash Flow -3,770,000,000 -3,141,700,000 -321,100,000 -340,900,000
Financing Activities
Debt Repayment -33,600,000 -44,900,000 -85,500,000 -47,000,000
Common Stock Issued/Repurchased -1,582,100,000 -293,000,000 14,300,000 -1,561,300,000
Dividends Paid 0 0 0 0
Financing Cash Flow -1,494,900,000 -562,200,000 -67,700,000 -1,478,000,000
Summary
Free Cash Flow -790,300,000 3,278,900,001 3,925,200,000 2,408,500,000
Net Change in Cash -5,800,100,000 -139,700,000 3,711,900,000 811,200,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -535,600,000 3,619,600,000 3,322,000,000 2,342,100,000 2,711,647,000
Depreciation & Amortization 207,200,000 181,300,000 148,300,000 125,600,000 109,515,000
Stock Based Compensation 698,500,000 581,200,000 491,300,000 441,400,000 429,461,000
Change in Working Capital -514,800,000 -265,700,000 340,800,000 -105,200,000 -54,454,000
Operating Cash Flow -492,600,000 3,537,300,000 4,129,900,000 2,643,500,000 3,253,505,000
Investing Activities
Capital Expenditure -297,700,000 -258,399,999 -204,700,000 -235,000,000 -259,798,000
Investments -297,700,000 -258,399,999 -204,700,000 -235,000,000 -259,798,000
Investing Cash Flow -3,770,000,000 -3,141,700,000 -321,100,000 -340,900,000 99,388,000
Financing Activities
Debt Repayment -33,600,000 -44,900,000 -85,500,000 -47,000,000 -42,275,000
Common Stock Issued/Repurchased -1,582,100,000 -293,000,000 14,300,000 -1,561,300,000 -739,407,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow -1,494,900,000 -562,200,000 -67,700,000 -1,478,000,000 -505,281,000
Summary
Free Cash Flow -790,300,000 3,278,900,001 3,925,200,000 2,408,500,000 2,993,707,000
Net Change in Cash -5,800,100,000 -139,700,000 3,711,900,000 811,200,000 2,868,164,000